BIOSCIENCE NEUTRACEUTICALS, INC. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
BIOSCIENCE NEUTRACEUTICALS, INC. reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of -$626.05 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromContinuingOperations · last filed 2020-03-30
- BIOSCIENCE NEUTRACEUTICALS, INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2019-12-31 was -$154.37K.
- BIOSCIENCE NEUTRACEUTICALS, INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2019-09-30 was -$9.27K.
- BIOSCIENCE NEUTRACEUTICALS, INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2019-06-30 was -$15.31K.
- BIOSCIENCE NEUTRACEUTICALS, INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2019-03-31 was -$447.10K.
- BIOSCIENCE NEUTRACEUTICALS, INC. income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2019 was -$626.05K.
- BIOSCIENCE NEUTRACEUTICALS, INC. income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2018 was -$61.26K.
- BIOSCIENCE NEUTRACEUTICALS, INC. income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2017 was -$51.47K.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$154.37K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$163.63K derived: sum of 2 quarters · filed 2020-03-30 | -$178.95K derived: sum of 3 quarters · filed 2020-03-30 | -$626.05K 10-K · filed 2020-03-30 |
| 2019-09-30 | -$9.27K 10-Q · filed 2019-11-12 | -$24.58K derived: sum of 2 quarters · filed 2019-11-12 | -$471.68K 10-Q · filed 2019-11-12 | -$491.45K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-06-30 | -$15.31K 10-Q · filed 2019-08-12 | -$462.41K 10-Q · filed 2019-08-12 | -$482.18K derived: sum of 3 quarters · filed 2020-03-30 | -$491.56K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-03-31 | -$447.10K 10-Q · filed 2019-05-15 | -$466.87K derived: sum of 2 quarters · filed 2020-03-30 | -$476.25K derived: sum of 3 quarters · filed 2020-03-30 | -$501.13K derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-12-31 | -$19.77K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$29.15K derived: sum of 2 quarters · filed 2020-03-30 | -$54.03K derived: sum of 3 quarters · filed 2020-03-30 | -$61.26K 10-K · filed 2020-03-30 |
| 2018-09-30 | -$9.38K 10-Q · filed 2019-11-12 | -$34.26K derived: sum of 2 quarters · filed 2019-11-12 | -$41.48K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$24.88K 10-Q · filed 2019-08-12 | -$32.10K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$7.22K 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | -$51.47K 10-K · filed 2019-04-09 |